查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1948161

全球类器官市场：机会与策略展望（至2034年）

Organoids Global Market Opportunities And Strategies To 2034
出版日期: | 出版商: The Business Research Company | 英文 393 Pages | 商品交期: 2-10个工作天内

价格
简介目录

全球类器官市场预计到2024年将达到约6.9006亿美元，自2019年以来年复合成长率（CAGR）为21.03%。预计该市场将从2024年的6.9006亿美元成长到2029年的16.0546亿美元，年复合成长率为18.40%。 2029年之后，预计该市场将继续以17.71%的年复合成长率成长，到2034年达到36.2743亿美元。

类器官是由干细胞培养而成的三维（3D）微型自组织组织结构，能够模拟真实器官的关键结构与功能特征。与传统的二维（2D）细胞培养相比，类器官具有更高的生理相关性，因为它们能够模拟复杂的细胞间相互作用、组织结构和生物学行为。类器官的主要目的是为疾病研究、药物研发、毒性测试和个人化医疗提供逼真的生物模型。

类器官市场是指机构、自营商或伙伴关係销售类器官产品，这些产品是试管内培养的器官的微型化、简化版三维模型。这些结构源自于干细胞或组织细胞，展现出逼真的微观解剖结构，并具有自我更新和分化的能力。

对製药和生物技术公司的投资增加

过去一段时间，对製药和生物技术公司投资的增加推动了类器官市场的成长。生物技术领域资金筹措的增加使各机构能够将更多资金投入到类器官等创新平台，因为他们认识到这些平台在简化药物研发流程和减少代价高昂的失败方面具有巨大潜力。更容易获得资金筹措也鼓励企业扩大实验室能力、取得专业的干细胞技术，并开发用于筛检和检验的先进类器官模型。例如，根据美国资讯服务公司Fierce Biotech在2025年9月发布的一份报告，美国国立卫生研究院（NIH）正在透过授予一项价值8700万美元的合约来建立一个标准化类器官建模（SOM）中心，从而进一步推进其最大限度减少药物测试中动物使用的目标。因此，对製药和生物技术公司投资的增加推动了类器官市场的成长。

重点研究血管化和功能成熟的类器官模型

类器官市场的企业正致力于研发血管化且功能成熟的类器官模型，以更真实地再现人体组织的结构和生理反应。这将推动疾病建模、再生医学和药物测试等领域的发展。例如，2025年6月，美国辛辛那提儿童医院医学中心成功开发出能够自我形成器官特异性血管的肝臟类器官，这标誌着组织工程领域的重大突破。研究人员利用多层凝胶技术，诱导肝窦血管前驱细胞迁移和分支，并与周围的肝细胞融合，最终形成功能性的肝窦血管系统。这些血管化的类器官能够产生关键的凝血因子，包括VIII因子，并能抑制血友病模型小鼠的出血。这种方法有望克服类器官长期存在的难题——缺乏内部血管系统——并为可移植肝组织的开发、先进的疾病建模以及凝血障碍的新治疗方法铺平道路。

全球类器官市场集中度较高，主要由几家大型企业主导。截至2024年，排名前十的市场竞争对手占据了33.53%的市场。

目录

第一章执行摘要

第二章 目录

第三章表格一览

第四章图表一览

第五章 报告结构

第六章 市场特征

  • 一般市场定义
  • 概述
  • 类器官市场定义与细分
  • 按产品分類的市场细分
    • 肝臟类器官
    • 结肠类器官
    • 肠道类器官
    • 其他类器官
  • 市场区隔：依来源
    • 多功能细胞
    • 器官特异性成体干细胞
  • 市场区隔：按应用
    • 发育生物学
    • 感染疾病的发病机制
    • 再生医学
    • 药物毒性和疗效测试
    • 药物发现与个人化医疗
    • 其他用途
  • 市场区隔：依最终用户划分
    • 医院和诊断中心
    • 生物技术和製药公司
    • 其他最终用户

第七章：主要市场趋势

  • 重点研究血管化和功能成熟的类器官模型
  • 开发可扩展、长寿命的功能性类器官模型
  • 创新和拓展用于生物治疗研究的类器官解决方案
  • 生命科学研究在专业化3D细胞模型生产上取得进展
  • 开发基于心臟类器官的试剂盒以改善心臟安全性测试

8. 类器官生长分析与策略分析框架

  • 类器官的PESTEL分析（政治、社会、技术、环境与法律因素）
    • 政治因素
    • 经济
    • 社会的
    • 技术的
    • 环境因素
    • 合法的
  • 终端用户（B2B）市场分析
    • 医院和诊断中心
    • 生物技术和製药公司
    • 其他最终用户
  • 类器官市场：成长率分析
  • 2019-2024年全球市场成长表现
    • 2019-2024年市场驱动因素
    • 2019-2024年市场限制因素
  • 全球市场成长预测，2024-2029年，2034年预测
  • 预期成长要素/驱动因素
    • 定量成长要素
    • 司机
    • 抑制因素
  • 类器官总潜在市场（TAM）
    • TAM比较分析

第九章 类器官市场：细分

  • 全球类器官市场：依产品、效能及预测划分，2019-2024年、2029年预测、2034年预测
  • 全球类器官市场：依来源、表现及预测（2019-2024年、2029年预测、2034年预测）
  • 全球类器官市场：依应用、效能和预测划分，2019-2024年、2029年预测、2034年预测
  • 全球类器官市场：依最终使用者、效能和预测划分，2019-2024年、2029年预测、2034年预测
  • 全球类器官市场：依类型（肝臟类器官）细分、表现及预测，2019-2024年、2029年预测、2034年预测
  • 全球类器官市场：细分：结直肠类器官，按类型、表现和预测（2019-2024 年、2029 年预测、2034 年预测）
  • 全球类器官市场：细分：肠道类器官，按类型、表现和预测（2019-2024年、2029年预测、2034年预测）
  • 全球类器官市场：细分：其他类器官，按类型、表现和预测（2019-2024 年、2029 年预测、2034 年预测）

第十章：类器官市场：区域与国家分析

  • 类器官市场：区域表现及预测，2019-2024年、2029年预测、2034年预测
  • 类器官市场：国家、表现及预测，2019-2024年、2029年预测、2034年预测

第十一章 亚太市场

第十二章 西欧市场

第十三章 东欧市场

第十四章 北美市场

第十五章：南美市场

第十六章 中东市场

第十七章：非洲市场

第十八章：竞争格局与公司概况

  • 公司简介
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Merck KGaA（Hubrecht Organoid Technology（HUB））
  • STEMCELL Technologies Inc
  • Danaher Corporation（Cellesce Ltd）

第十九章：其他领先和创新企业

  • Sartorius AG
  • Charles River Laboratories International, Inc.
  • Bio-Techne Corp.
  • Greiner Bio-One International GmbH
  • ACROBiosystems Inc.
  • Crown Bioscience（OcellO BV）
  • InSphero AG
  • ATCC（American Type Culture Collection）
  • Axol Bioscience Ltd.
  • Newcells Biotech Ltd.
  • Pandorum Technologies Pvt. Ltd.
  • 3Dnamics Inc.
  • 3D Biotek LLC
  • AMS Biotechnology（Europe）Limited
  • CelVivo ApS

第二十章：竞争标竿分析

第21章 竞争格局分析

第22章 重大併购

  • Merck Group Acquired HUB Organoids Holding BV
  • Bruker Corporation Acquired Acquifer Imaging
  • Molecular Devices Acquired Cellesce

第23章：类器官研究的最新趋势

  • 标准化类器官平台革新人工智慧驱动的药物测试
  • 光学石墨烯刺激技术革新脑类器官与神经生物混合研究
  • 3D类器官平台革新精准医疗药物筛检

第24章：机会与策略

  • 2029年类器官市场－最具发展机会的国家
  • 2029年类器官市场－最具新兴机会的细分市场
  • 类器官市场成长策略至2029年
    • 基于市场趋势的策略
    • 竞争对手策略

第25章 类器官市场：结论与建议

  • 结论
  • 建议

第26章附录

简介目录
Product Code: HS5MORGA01_O25Q4

Organoids are three-dimensional (3D) miniaturized and self-organizing tissue structures grown from stem cells that mimic key structural and functional features of real organs. They reproduce complex cellular interactions, architecture and biological behavior, making them more physiologically relevant than traditional 2D cell cultures. The primary purpose of organoids is to provide realistic biological models for disease research, drug discovery, toxicology testing and personalized medicine.

The organoids market consists of sales, by entities (organizations, sole traders, or partnerships), of organoids products that are miniaturized and simplified three-dimensional versions of organs produced in vitro. These structures are derived from stem cells or tissue cells and exhibit realistic microanatomy with self-renewal and differentiation capacities.

The global organoids market reached a value of nearly $690.06 million in 2024, having grown at a compound annual growth rate (CAGR) of 21.03% since 2019. The market is expected to grow from $690.06 million in 2024 to $1,605.46 million in 2029 at a rate of 18.40%. The market is then expected to grow at a CAGR of 17.71% from 2029 and reach $3,627.43 million in 2034.

Rise In Investments In Pharmaceutical And Biotechnology Companies

A Rise in investments in pharmaceutical and biotechnology companies contributed to the growth of the organoids market in the historic period. As funding surged within the biotech sector, organizations were able to allocate greater financial resources toward innovative platforms such as organoids, recognizing their potential to streamline drug development and reduce costly failures. Enhanced capital availability encouraged companies to expand laboratory capacities, acquire specialized stem cell technologies, and develop sophisticated organoid-based models for screening and validation. For instance, in September 2025, according to the Fierce Biotech, a US-based information services company, reported that the National Institutes of Health (NIH) is advancing its goal of minimizing animal use in drug testing by awarding $87 million in contracts to establish the Standardized Organoid Modeling (SOM) Cente. Therefore, Rise in investments in pharmaceutical and biotechnology companies drove the growth of the organoids market.

Focus On Vascularized And Functionally Mature Organoid Models

Companies operating in the organoids market are focusing on vascularized and functionally mature organoid models that better replicate human tissue architecture and physiological responses, enabling advancements in disease modeling, regenerative therapies, and drug testing applications. For instance, in June 2025, Cincinnati Children's Hospital Medical Center, a US-based hospital, engineered a liver organoid capable of forming its own organ-specific blood vessels, marking a significant advancement in tissue engineering. Using a multilayer gel technique, liver sinusoidal progenitor cells were guided to migrate, sprout, and integrate with surrounding liver cells to form functional sinusoid-like vasculature. These vascularized organoids also produced critical coagulation factors, including Factor VIII, and were able to correct bleeding in hemophilia-model mice. The approach helps overcome the long-standing limitation of organoids lacking internal vasculature, and may pave the way for transplantable liver tissue, enhanced disease models, and novel therapies for coagulation disorders.

The global organoids markets is concentrated, with large players operating in the market. The top 10 competitors in the market made up 33.53% of the total market in 2024.

Organoids Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global organoids market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for organoids? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The organoids market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider organoids market; and compares it with other markets.

The report covers the following chapters

  • Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by source, by applications and end-user.
  • Key Trends: - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework: - Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Global Market Size And Growth: - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis: - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by product, by source, by application and end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth: - Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape: - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies: - Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking: - Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard: - Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions: - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments: - Information on recent developments in the market covered in the report
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for organoids providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix: - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product: Hepatic Organoid; Colorectal Organoid; Intestinal Organoid; Other Organoid
  • 2) By Source: Pluripotent Stem Cells; Organ-Specific Adult Stem Cells
  • 3) By Application: Developmental Biology; Disease Pathology Of Infectious Disease; Regenerative Medicine; Drug Toxicity And Efficacy Testing; Drug Discovery And Personalized Medicine; Other Applications
  • 4) By End-User: Hospitals And Diagnostic Centers; Biotechnology And Pharmaceutical Companies; Other End-Users
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Corning Incorporated; Merck KGaA (Hubrecht Organoid Technology (HUB)); STEMCELL Technologies; Danaher Corporation (Cellesce Ltd)
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; organoids indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes."

Table of Contents

1 Executive Summary

  • 1.1 Organoids - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Organoids Market Definition And Segmentations
  • 6.4 Market Segmentation By Product
    • 6.4.1 Hepatic Organoid
    • 6.4.2 Colorectal Organoid
    • 6.4.3 Intestinal Organoid
    • 6.4.4 Other Organoid
  • 6.5 Market Segmentation By Source
    • 6.5.1 Pluripotent Stem Cells
    • 6.5.2 Organ-Specific Adult Stem Cells
  • 6.6 Market Segmentation By Application
    • 6.6.1 Developmental Biology
    • 6.6.2 Disease Pathology Of Infectious Disease
    • 6.6.3 Regenerative Medicine
    • 6.6.4 Drug Toxicity And Efficacy Testing
    • 6.6.5 Drug Discovery And Personalized Medicine
    • 6.6.6 Other Applications
  • 6.7 Market Segmentation By End-User
    • 6.7.1 Hospitals And Diagnostic Centers
    • 6.7.2 Biotechnology And Pharmaceutical Companies
    • 6.7.3 Other End-Users

7 Major Market Trends

  • 7.1 Focus On Vascularized And Functionally Mature Organoid Models
  • 7.2 Development Of Scalable, Long-Lasting Functional Organoid Models
  • 7.3 Innovation In Organoid Solutions For Biotherapeutic Research And To Expand Solutions
  • 7.4 Advancements In Life Science Research For The Production Of Specialized 3D Cell Models
  • 7.5 Development Of Cardiac Organoids-Based Kits For Improved Cardiac Safety Testing

8 Organoids Growth Analysis And Strategic Analysis Framework

  • 8.1 Organoids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
    • 8.1.1 Political
    • 8.1.2 Economic
    • 8.1.3 Social
    • 8.1.4 Technological
    • 8.1.5 Environmental
    • 8.1.6 Legal
  • 8.2 Analysis Of End User (B2B) Market
    • 8.2.1 Hospitals And Diagnostic Centers
    • 8.2.2 Biotechnology And Pharmaceutical Companies
    • 8.2.3 Other End-Users
  • 8.3 Organoids Market Growth Rate Analysis
  • 8.4 Global Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 8.4.1 Market Drivers 2019 - 2024
    • 8.4.2 Market Restraints 2019 - 2024
  • 8.5 Global Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
  • 8.6 Forecast Growth Contributors/Factors
    • 8.6.1 Quantitative Growth Contributors
    • 8.6.2 Drivers
    • 8.6.3 Restraints
  • 8.7 Organoids Total Addressable Market (TAM)
    • 8.7.1 TAM Comparison Analysis

9 Organoids Market Segmentation

  • 9.1 Global Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.2 Global Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.3 Global Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.4 Global Organoids Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.5 Global Organoids Market, Sub-Segmentation Of Hepatic Organoid, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.6 Global Organoids Market, Sub-Segmentation Of Colorectal Organoid, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.7 Global Organoids Market, Sub-Segmentation Of Intestinal Organoid, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.8 Global Organoids Market, Sub-Segmentation Of Other Organoid, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Organoids Market, Regional and Country Analysis

  • 10.1 Organoids Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.2 Organoids Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

  • 11.1 Summary
  • 11.2 Market Overview
    • 11.2.1 Region Information
    • 11.2.2 Market Information
    • 11.2.3 Background Information
    • 11.2.4 Government Initiatives
    • 11.2.5 Regulations
    • 11.2.6 Regulatory Bodies
    • 11.2.7 Major Associations
    • 11.2.8 Taxes Levied
    • 11.2.9 Corporate Tax Structure
    • 11.2.10 Investments
    • 11.2.11 Major Companies
  • 11.3 Asia-Pacific Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.4 Asia-Pacific Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.5 Asia-Pacific Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.6 Asia-Pacific Organoids Market: Country Analysis
  • 11.7 China Market
  • 11.8 Summary
  • 11.9 Market Overview
    • 11.9.1 Country Information
    • 11.9.2 Market Information
    • 11.9.3 Background Information
    • 11.9.4 Government Initiatives
    • 11.9.5 Regulations
    • 11.9.6 Regulatory Bodies
    • 11.9.7 Major Associations
    • 11.9.8 Taxes Levied
    • 11.9.9 Corporate Tax Structure
    • 11.9.10 Investments
    • 11.9.11 Major Companies
  • 11.10 China Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.11 China Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.12 China Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.13 India Market
  • 11.14 India Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.15 India Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.16 India Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.17 Japan Market
  • 11.18 Summary
  • 11.19 Market Overview
    • 11.19.1 Country Information
    • 11.19.2 Market Information
    • 11.19.3 Background Information
    • 11.19.4 Government Initiatives
    • 11.19.5 Regulations
    • 11.19.6 Regulatory Bodies
    • 11.19.7 Major Associations
    • 11.19.8 Taxes Levied
    • 11.19.9 Corporate Tax Structure
    • 11.19.10 Investments
    • 11.19.11 Major Companies
  • 11.20 Japan Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.21 Japan Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.22 Japan Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.23 Australia Market
  • 11.24 Australia Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.25 Australia Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.26 Australia Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.27 Indonesia Market
  • 11.28 Indonesia Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.29 Indonesia Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.30 Indonesia Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.31 South Korea Market
  • 11.32 Summary
  • 11.33 Market Overview
    • 11.33.1 Country Information
    • 11.33.2 Market Information
    • 11.33.3 Background Information
    • 11.33.4 Government Initiatives
    • 11.33.5 Regulations
    • 11.33.6 Regulatory Bodies
    • 11.33.7 Major Associations
    • 11.33.8 Taxes Levied
    • 11.33.9 Corporate Tax Structure
    • 11.33.10 Investments
    • 11.33.11 Major Companies
  • 11.34 South Korea Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.35 South Korea Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.36 South Korea Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate tax structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Western Europe Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Western Europe Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Western Europe Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.6 Western Europe Organoids Market: Country Analysis
  • 12.7 UK Market
  • 12.8 UK Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.9 UK Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.10 UK Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.11 Germany Market
  • 12.12 Germany Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 Germany Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.14 Germany Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.15 France Market
  • 12.16 France Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 France Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.18 France Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.19 Italy Market
  • 12.20 Italy Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.21 Italy Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.22 Italy Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.23 Spain Market
  • 12.24 Spain Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 Spain Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.26 Spain Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Major Companies
  • 13.3 Eastern Europe Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Eastern Europe Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Eastern Europe Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 Eastern Europe Organoids Market: Country Analysis
  • 13.7 Russia Market
  • 13.8 Russia Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.9 Russia Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.10 Russia Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 North America Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 North America Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 North America Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 North America Organoids Market: Country Analysis
  • 14.7 USA Market
  • 14.8 Summary
  • 14.9 Market Overview
    • 14.9.1 Country Information
    • 14.9.2 Market Information
    • 14.9.3 Background Information
    • 14.9.4 Government Initiatives
    • 14.9.5 Regulations
    • 14.9.6 Regulatory Bodies
    • 14.9.7 Major Associations
    • 14.9.8 Taxes Levied
    • 14.9.9 Corporate Tax Structure
    • 14.9.10 Investments
    • 14.9.11 Major Companies
  • 14.10 USA Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.11 USA Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.12 USA Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.13 Canada Market
  • 14.14 Summary
  • 14.15 Market Overview
    • 14.15.1 Country Information
    • 14.15.2 Market Information
    • 14.15.3 Background Information
    • 14.15.4 Government Initiatives
    • 14.15.5 Regulations
    • 14.15.6 Regulatory Bodies
    • 14.15.7 Major Associations
    • 14.15.8 Taxes Levied
    • 14.15.9 Corporate Tax Structure
    • 14.15.10 Investments
    • 14.15.11 Major Companies
  • 14.16 Canada Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.17 Canada Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.18 Canada Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 South America Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 South America Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 South America Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.6 South America Organoids Market: Country Analysis
  • 15.7 Brazil Market
  • 15.8 Brazil Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.9 Brazil Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.10 Brazil Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 Middle East Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 Middle East Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 Middle East Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Major Companies
  • 17.3 Africa Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 Africa Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.5 Africa Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

  • 18.1 Company Profiles
  • 18.2 Thermo Fisher Scientific Inc
    • 18.2.1 Company Overview
    • 18.2.2 Products And Services
    • 18.2.3 Business Strategy
    • 18.2.4 Financial Overview
  • 18.3 Corning Inc
    • 18.3.1 Company Overview
    • 18.3.2 Products And Services
    • 18.3.3 Business Strategy
    • 18.3.4 Financial Overview
  • 18.4 Merck KGaA (Hubrecht Organoid Technology (HUB))
    • 18.4.1 Company Overview
    • 18.4.2 Products And Services
    • 18.4.3 Business Strategy
    • 18.4.4 Financial Overview
  • 18.5 STEMCELL Technologies Inc
    • 18.5.1 Company Overview
    • 18.5.2 Products And Services
    • 18.5.3 Business Strategy
    • 18.5.4 Financial Overview
  • 18.6 Danaher Corporation (Cellesce Ltd)
    • 18.6.1 Company Overview
    • 18.6.2 Products And Services
    • 18.6.3 Business Strategy
    • 18.6.4 Financial Overview

19 Other Major And Innovative Companies

  • 19.1 Sartorius AG
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
  • 19.2 Charles River Laboratories International, Inc.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
  • 19.3 Bio-Techne Corp.
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
  • 19.4 Greiner Bio-One International GmbH
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
  • 19.5 ACROBiosystems Inc.
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
  • 19.6 Crown Bioscience (OcellO B.V.)
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
  • 19.7 InSphero AG
    • 19.7.1 Company Overview
    • 19.7.2 Products And Services
  • 19.8 ATCC (American Type Culture Collection)
    • 19.8.1 Company Overview
    • 19.8.2 Products And Services
  • 19.9 Axol Bioscience Ltd.
    • 19.9.1 Company Overview
    • 19.9.2 Products And Services
  • 19.10 Newcells Biotech Ltd.
    • 19.10.1 Company Overview
    • 19.10.2 Products And Services
  • 19.11 Pandorum Technologies Pvt. Ltd.
    • 19.11.1 Company Overview
    • 19.11.2 Products And Services
  • 19.12 3Dnamics Inc.
    • 19.12.1 Company Overview
    • 19.12.2 Products And Services
  • 19.13 3D Biotek LLC
    • 19.13.1 Company Overview
    • 19.13.2 Products And Services
  • 19.14 AMS Biotechnology (Europe) Limited
    • 19.14.1 Company Overview
    • 19.14.2 Products And Services
  • 19.15 CelVivo ApS
    • 19.15.1 Company Overview
    • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Merck Group Acquired HUB Organoids Holding B.V.
  • 22.2 Bruker Corporation Acquired Acquifer Imaging
  • 22.3 Molecular Devices Acquired Cellesce

23 Recent Developments In Organoids

  • 23.1 Standardized Organoid Platform Transforms AI-Driven Drug Testing
  • 23.2 Optical Graphene Stimulation Transforms Brain Organoid and Neuro-Biohybrid Research
  • 23.3 3D Organoid Platform Transforms Drug Screening for Precision Medicine

24 Opportunities And Strategies

  • 24.1 Organoids Market In 2029 - Countries Offering Most New Opportunities
  • 24.2 Organoids Market In 2029 - Segments Offering Most New Opportunities
  • 24.3 Organoids Market In 2029 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Organoids Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer